Molecule Details
InChIKeyQOYHHIBFXOOADH-UHFFFAOYSA-N
Compound NameFluspirilene
Canonical SMILESO=C1NCN(c2ccccc2)C12CCN(CCCC(c1ccc(F)cc1)c1ccc(F)cc1)CC2
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)16
Pfam Stratification Cross-Family
Avg pChEMBL7.11
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB04842
Drug NameFluspirilene
CAS Number1841-19-6
Groups approved withdrawn
ATC Codes N05AG01
DescriptionA long-acting injectable antipsychotic agent used for chronic schizophrenia.

Categories: Agents causing hyperkalemia Antiarrhythmic agents Antidepressive Agents Antipsychotic Agents Bradycardia-Causing Agents Calcium Channel Blockers Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Substrates Diphenylbutylpiperidine Derivatives Dopamine Agents Dopamine Antagonists Dopamine D2 Receptor Antagonists Imidazoles Moderate Risk QTc-Prolonging Agents Nervous System Neurotoxic agents Neurotransmitter Agents Piperidines Psycholeptics Psychotropic Drugs QTc Prolonging Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 5-HT2 Receptor Antagonists Serotonin 5-HT2A Receptor Antagonists Serotonin Agents Serotonin Receptor Antagonists Spiro Compounds Tranquilizing Agents
Cross-references: BindingDB: 26948 ChEBI: 93369 CHEMBL46516 ChemSpider: 3279 Drugs Product Database (DPD): 2260 Guide to Pharmacology: 85 IUPHAR: 85 D02629 PharmGKB: PA162565878 PubChem:3396 PubChem:46508202 RxCUI: 4507 Therapeutic Targets Database: DAP000980 Wikipedia: Fluspirilene ZINC: ZINC000000537755
Target Activities (16)
Target Gene Organism Category Pfam pChEMBL Type Source
P14416 DRD2 Homo sapiens Human PF00001 9.4 Ki BindingDB
P35462 DRD3 Homo sapiens Human PF00001 8.4 Ki BindingDB
P21917 DRD4 Homo sapiens Human PF00001 8.3 Ki BindingDB
P28223 HTR2A Homo sapiens Human PF00001 8.0 Ki BindingDB
P35367 HRH1 Homo sapiens Human PF00001 7.9 Ki BindingDB
P18089 ADRA2B Homo sapiens Human PF00001 7.3 Ki BindingDB
P08908 HTR1A Homo sapiens Human PF00001 7.2 Ki BindingDB
P18825 ADRA2C Homo sapiens Human PF00001 7.2 Ki BindingDB
P41595 HTR2B Homo sapiens Human PF00001 6.8 Ki ChEMBL;BindingDB
P41146 OPRL1 Homo sapiens Human PF00001 6.3 Ki ChEMBL;BindingDB
P07550 ADRB2 Homo sapiens Human PF00001 6.3 Ki BindingDB
P08913 ADRA2A Homo sapiens Human PF00001 6.2 Ki BindingDB
P08588 ADRB1 Homo sapiens Human PF00001 6.2 Ki BindingDB
P20366 TAC1 Homo sapiens Human PF02202 6.0 Ki BindingDB
P21731 TBXA2R Homo sapiens Human PF00001 6.0 Ki BindingDB
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 6.0 Ki BindingDB
DrugBank Target Actions (4)
Target Gene Target Name Action Type
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P14416 DRD2 D(2) dopamine receptor antagonist targets
P28223 HTR2A 5-hydroxytryptamine receptor 2A antagonist targets
Q06432 CACNG1 Voltage-dependent calcium channel gamma-1 subunit inhibitor targets